Neela Therapeutics, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-11-24.
Neela Therapeutics, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on November 24, 2025. The filing reports $13.82M sold. Its industry group is Other Health Care. It names PJ Anand (Executive Officer, Director), Norbert Riedel (Director), Richard Upton (Director) (SEC Form D/A, November 24, 2025).
Is this your company?
Sell to companies like Neela Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Neela Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Neela Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in Massachusetts, filed in November 2025, largest first.
Get an email when Neela Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Neela Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Neela Therapeutics, Inc. →Get the full cited report on Neela Therapeutics, Inc.
What the filing shows about Neela Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Neela Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Neela Therapeutics, Inc.'s address as 96 Robbs Hill Road, Lunenburg, MA 01462.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Neela Therapeutics, Inc. →
Amended on 2026-05-26: the offering size changed from $13,510,000 to $21,510,000; the amount sold changed from $12,010,000 to $13,821,643; the number of investors changed from 17 to 21. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Neela Therapeutics, Inc. See pricing
Neela Therapeutics, Inc. is a registered filer with the SEC (CIK 2090797) and has filed since 2025-11-24. 1 filing is on record, the latest on 2025-11-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Neela Therapeutics, Inc.'s Form D of 2025-11-24 names Pj Anand, Norbert Riedel, Richard Upton and 4 more as its officers, directors or promoters.
Its new offerings report $12.01M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week. The dot is this raise, $13.82M, on the same scale — one filing against the whole group's total, so it sits low by construction.
PJ Anand is named as Executive Officer and Director on the Form D that Neela Therapeutics, Inc. filed with the SEC on 24 November 2025, one of 6 people that filing names.
Norbert Riedel is named as Director on the Form D that Neela Therapeutics, Inc. filed with the SEC on 24 November 2025, one of 6 people that filing names.
Richard Upton is named as Director on the Form D that Neela Therapeutics, Inc. filed with the SEC on 24 November 2025, one of 6 people that filing names.
David Donabedian is named as Director on the Form D that Neela Therapeutics, Inc. filed with the SEC on 24 November 2025, one of 6 people that filing names.
Edgar Jannotta Jr. is named as Director on the Form D that Neela Therapeutics, Inc. filed with the SEC on 24 November 2025, one of 6 people that filing names.
Stephen Oesterle is named as Director on the Form D that Neela Therapeutics, Inc. filed with the SEC on 24 November 2025, one of 6 people that filing names.
6 people named on the filing — 1 holding an executive role and 5 as directors only.
Named as of the 2025-11-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Neela Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Neela Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neela Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Neela Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Neela Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Neela Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/neela-therapeutics-inc-form-d-25000001